Panel discussion on how the management of breast cancer and breast diseases is de-escalating without impacting survival - Global variations. [each panelist will have 10 minutes to discuss their assigned topic followed by case scenarios from moderators to have panelists answer from their countries perspective].
| Time | Session |
|---|---|
|
10:30
10:48
|
TARGETED AXILLARY DISSECTION (FOLLOWING NEOADJUVANT SYSTEMIC THERAPY FOR (HER2+ OR TNBC) OR UPFRONT SURGERY IN HORMONE RECEPTOR POSITIVE) FOR CN1 DISEASE
223-1
Room: Molino Rey B (Floor 5)
|
|
10:48
11:06
|
OMISSION OF RADIATION POST BREAST CONSERVING SURGERY
223-2
Room: Molino Rey B (Floor 5)
|
|
11:06
11:24
|
OMISSION OF SENTINEL LYMPH NODE BIOPSY FOR INVASIVE BREAST CANCER (SOUND, NAUTILUS, SOAPET, BOOG 2013-08, INSEMA)
223-3
Room: Molino Rey B (Floor 5)
|
|
11:24
11:42
|
ACTIVE SURVEILLANCE FOR DCIS (COMET TRIAL, LORD, LORIS)
223-4
Room: Molino Rey B (Floor 5)
|
|
11:42
12:00
|
OMISSION OF BREAST SURGERY IN EARLY BREAST CANCER
223-5
Room: Molino Rey B (Floor 5)
|